Nigel Thompson worked as a stockbroker for Cantor Fitzgerald. His office was on the 105th floor of the North Tower of the World Trade Centre - the first twin tower that was attacked. Brother Neil ...

Cantor Fitzgerald doubled down on its bearish stance toward stocks on Monday, reaffirming its negative outlook with the statement, “we continue to be bearish on equities” in an investor note ...

Cantor Fitzgerald assumed coverage of Aclaris Therapeutics (ACRS) with an Overweight rating. Cantor is bullish on the TSLP and IL-4R bispecific, which looks differentiated, and even early proof-of ...

Bradmer Pharmaceuticals Inc. (TSE:GLX – Free Report) – Research analysts at Cantor Fitzgerald cut their FY2025 earnings estimates for shares of Bradmer Pharmaceuticals in a note issued to ...

OKTA stock opened at $104.69 on Monday. The company has a market cap of $18.17 billion, a PE ratio of -299.11, a price-to-earnings-growth ratio of 6.42 and a beta of 1.09. The company has a ...

Cantor Fitzgerald upgraded Tesla (TSLA, Financials) to Overweight from Neutral, citing a buying opportunity following the recent sell-off, the firm announced after a site visit to Tesla's ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Cartesian Therapeutics (NASDAQ:RNAC), currently trading at $15.80, with a steady price target of $22.00. The stock has experienced ...

On Wednesday, Cantor Fitzgerald outlined a strategic approach for investors in the smid cap biotech sector, emphasizing the importance of downside protection and the potential for significant upside.

Tesla (NASDAQ:TSLA) attracted an upgrade from Cantor Fitzgerald on Wednesday after the firm visited the company's Gigafactory and AI data centers in Austin. The firm moved Tesla (NASDAQ ...

Cantor Fitzgerald biotech analysts slammed the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., calling on the Trump administration to “re-evaluate” his role after a ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The main driver of the rating is the parent firm's five-year risk-adjusted success ratio of 81%. The measure ...

Fintel reports that on March 19, 2025, Cantor Fitzgerald upgraded their outlook for Tesla (SNSE:TSLACL) from Neutral to Overweight. There are 5,232 funds or institutions reporting positions in Tesla.